# Allogeneic Stem Cell Therapy in Heart Failure

> **NCT03092284** · PHASE2 · COMPLETED · sponsor: **JKastrup** · enrollment: 81 (actual)

## Conditions studied

- Heart Failure

## Interventions

- **BIOLOGICAL:** Cardiology Stem Cell Centre Adipose Stem Cell (CSCC_ASC)
- **BIOLOGICAL:** Placebo

## Key facts

- **NCT ID:** NCT03092284
- **Lead sponsor:** JKastrup
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2015-09
- **Primary completion:** 2021-07
- **Final completion:** 2022-07
- **Target enrollment:** 81 (ACTUAL)
- **Last updated:** 2022-09-06


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03092284

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03092284, "Allogeneic Stem Cell Therapy in Heart Failure". Retrieved via AI Analytics 2026-06-16 from https://api.ai-analytics.org/clinical/NCT03092284. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*